Oct 2026· EBioMedicine· Vol 133, pp.
106521
· 0 citations· 49 references
Medicine
TL;DR
Gut microbiome dysbiosis in infants with IBS risk is present many years prior to diagnosis and includes early disruptions in fermentation, redox balance, and amine metabolism that potentially compromise epithelial resilience and promote visceral hypersensitivity.
Abstract
Background
The infant gut microbiome undergoes rapid maturation that shapes lifelong gastrointestinal health. Although adults with irritable bowel syndrome (IBS) show characteristic microbial and metabolic alterations, it remains unclear whether these differences precede disease onset. Here, microbiome composition and function in infancy were prospectively associated with future IBS development.
Methods
Stool samples collected from the All Babies in Southeast Sweden (ABIS) cohort at a mean age of 12.4 (±1.5) months, were analysed using a nested case-control design. Cases included future IBS and/or pelvic and abdominal pain, with the average time between age at stool collection and diagnosis being 11.8 (±5.2) years and a mean age at diagnosis of 12.8 (±5.2) years. Microbial composition was profiled with 16S rRNA gene sequencing (n = 396). Data were processed with DADA2, taxonomically assigned using SILVA database, and predicted functionally with PICRUSt2. Descriptive statistics were analysed using χ2 or Fisher's exact test, global differences with PERMANOVA, differential abundance with ANCOM-BC2, and pathway enrichment with GSEA.
Findings
Infants with future IBS risk demonstrated microbial divergence, marked by depletion of short-chain fatty acid producers and expansion of facultative and mucosa-disruptive taxa. Inferred functional profiles exhibited reduced fermentative capacity, greater respiratory potential, accelerated degradation of neuroactive aromatic amines, and case-enrichment of cytochrome bc1 complex respiratory unit.
Interpretation
Gut microbiome dysbiosis in infants with IBS risk is present many years prior to diagnosis and includes early disruptions in fermentation, redox balance, and amine metabolism that potentially compromise epithelial resilience and promote visceral hypersensitivity. Early detection of microbiome dysbiosis suggests probiotic-based interventions.
Funding
Barndiabetesfonden; Swedish Council for Working Life and Social Research; Swedish Research Council; Östgöta Brandstodsbolag; Medical Research Council of Southeast Sweden; JDRF-Wallenberg Foundation; Linköping University; Horizon Europe INITIALISE grant.
Background: Inflammatory bowel disease and irritable bowel syndrome commonly present with overlapping gastrointestinal symptoms but differ substantially in their underlying mechanisms. Objective: To compare the gut microbiome composition and functional metagenomic profiles of patients with inflammatory bowel disease an...
Rashid Karim, Muhammad Usman Khan, N. Hassan et al.· International Journal of Dru...· 0 citations
Myotonic Dystrophy type 1 (DM1) is a complex multisystem disorder, and affected children commonly present with gastrointestinal and neurodevelopmental challenges. Despite the high prevalence of these symptoms, their underlying mechanisms remain poorly understood. The gut microbiome is known to be involved in gastrointe...
Anne M. van Uden, H. Zweers, A. Vásquez et al.· Journal of Neuromuscular Dis...· 0 citations
INTRODUCTION
Overactive bladder (OAB) affects up to 10% of healthy children, with poorly understood mechanisms. Recent adult data implicate the urogenital microbiome in lower urinary tract symptoms. This pilot study explored the relationship between the urogenital microbiome and OAB in children.
METHODS
A prospective...
L. Moratilla-Lapeña, Jesús Mingorance, B. Nava et al.· Medical Principles and Pract...· 0 citations
Inherited metabolic disorders (IMDs) comprise more than 1,400 rare genetic conditions affecting paediatric patients worldwide. Despite advances in newborn screening and dietary management, many children experience chronic complications, gastrointestinal symptoms, and reduced health-related quality of life (HRQoL). Emer...
J. Dumbuya, Yuan-Long Li, Bo He et al.· Frontiers in Microbiology· 0 citations
Genetically predicted IBS risk was associated with lower abundances of Turicibacter and Slackia, whereas no robust reverse associations were observed for FD, and several microbial taxa are identified as candidates for further mechanistic and clinical validation rather than established risk factors or therapeutic target...
Yu-Tong Cheng, Qiu-Ai Shu, Zi-Wei Wang et al.· Experimental biology and med...· 0 citations
The findings suggest that early-life factors, including antibiotic exposure, prematurity, complex clinical conditions, and surgical interventions, may substantially affect microbial colonization, and alterations may be associated with an increased risk of complications and systemic inflammation.
Marsiglia Riccardo, D. D. De Rose, Panebianco Stefania et al.· Frontiers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.